Worth reading
39Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Announced details
Online Company Briefing for Individual Investors
Launch dateScheduled for 19 May 2026 (Tuesday), 19:45–20:30.
Relationship between the counterparty and the company
Modalis Therapeutics Corporation4883
Relationship with the Company
SBI Securities Co., Ltd. will operate the briefing.
CounterpartySBI SECURITIES CO., LTD.
Company operating the briefing. Other information, including its location, representative, business activities, capital and year of establishment, is Not disclosed.
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Online Company Briefing for Individual Investors |
| Counterparty | SBI SECURITIES CO., LTD. |
| Counterparty overview | Company operating the briefing. Other information, including its location, representative, business activities, capital and year of establishment, is Not disclosed. |
| Relationship with the Company | SBI Securities Co., Ltd. will operate the briefing. |
| Launch date | Scheduled for 19 May 2026 (Tuesday), 19:45–20:30. |
Items this document does not state (13)
Contract ValueOffering priceContract DateApplicable areaAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To explain the company’s business overview, development status, future business strategy and financial strategy to individual investors.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.